4//SEC Filing
McAnear Justin J. 4
Accession 0001610717-23-000064
CIK 0001770787other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 5:48 PM ET
Size
8.9 KB
Accession
0001610717-23-000064
Insider Transaction Report
Form 4
McAnear Justin J.
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2023-05-23$55.06/sh−565$31,111→ 100,462 total - Sale
Class A Common Stock
2023-05-23$55.07/sh−194$10,683→ 101,933 total - Sale
Class A Common Stock
2023-05-23$55.06/sh−465$25,604→ 101,468 total - Sale
Class A Common Stock
2023-05-23$55.06/sh−441$24,283→ 101,027 total
Footnotes (2)
- [F1]The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 617 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 12, 2023.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001786386
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 5:48 PM ET
- Size
- 8.9 KB